Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Dabigatran MeSH Descriptor Data 2026


MeSH Heading
Dabigatran
Tree Number(s)
D03.383.725.192
D03.633.100.103.280
Unique ID
D000069604
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069604
Scope Note
A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.
Entry Term(s)
BIBR 1048
Dabigatran Etexilate
Dabigatran Etexilate Mesylate
N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine
Pradaxa
Pharm Action
Antithrombins
Registry Numbers
I0VM4M70GC
2E18WX195X
0
SC7NUW5IIT
Related Numbers
2E18WX195X
SC7NUW5IIT
Public MeSH Note
2016; DABIGATRAN was indexed under BENZIMIDOAZOLES and BETA-ALANINE 2010-2015; DABIGATRAN ETEXILATE was indexed under BENZIMIDOAZOLES and PYRIDINES 2002-2015
History Note
2016 (2002)
Date Introduced
2016/01/01
Last Updated
2016/05/28
Dabigatran Preferred
Dabigatran Etexilate Narrower
BIBR 1048 Narrower
Pradaxa Narrower
Dabigatran Etexilate Mesylate Narrower
page delivered in 0.18s